Press Releases from Crigler-Najjar Syndrome Therapeutics- Pharma Proff (1 total)
Crigler-Najjar Syndrome Therapeutics- Pipeline Analysis 2018
Crigler-Najjar syndrome is a severe condition, characterized by the high concentration of bilirubin (a toxic substance) in blood. Bilirubin is produced by liver due to the breakdown of red blood cells.
Download the sample report at: https://www.pharmaproff.com/request-sample/1022
The toxic form of bilirubin (unconjugated bilirubin), is converted into nontoxic form (conjugated bilirubin). Patients suffering with Crigler-Najjar syndrome have a high level of unconjugated form of bilirubin in blood. Due to its high concentration,…
